Historical AI Consensus
This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.
- Symbol
- TER.NASDAQ
- Batch
- 7
- Published
- September 20, 2026
- AI Advisors
- 14
Historical AI Consensus Investment Thesis
Teradyne (TER) Stock Forecast and AI Rating
Forecast targets and rating
Published batch rating
NEUTRAL
Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.
1-Year
SELL ALL$312
-15.9%-15.7% incl. dividends5-Year
NEUTRAL$419
+12.8%+14.5% incl. dividendsPublished batch insight
AI Hardware Complexity Clashes With Looming Chip Tester Capacity Digestion Cycle
There is high consensus that advanced packaging and high-bandwidth memory structurally multiply automated test duration, yet sharp divergence over whether front-loaded capacity purchases trigger severe intermediate multiple compression. The primary driver is multi-die chiplet complexity, while the decisive risk is cyclical tester digestion under restrictive monetary regimes.
This analysis preserves the original published batch. Audit published forecasts in full transparency
Ray Dalio (Strategist), Superintelligence (Anthropologist), Universal Investor (Polymath), Elon Musk (Visionary), J.P. Morgan (Titan), Machiavelli (Insider), Sherlock Holmes (Whistleblower), Warren Buffett (Value Purist), Michael Burry (Vulture). Some archetypes run in multiple modes, resulting in 14 advisors total.
Gemini
Claude
ChatGPTFull published thesis
Executive Summary
If you invested $10,000 in Teradyne at the forecast anchor (2026-09-18): $11,450 in five years versus $13,892 for S&P 500 benchmark.
* Return is calculated incl. 0.3% net dividend yield for Teradyne.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each stepView tableClose table
Frozen forecast from 18 Sept 2026. Prices in USD; returns exclude dividends. Each quarter is compounded from the previous quarter.
Swipe the table horizontally to read every column.
| Quarter | Target (USD) | Quarter return | Total return | Forecast rationale |
|---|---|---|---|---|
| Q4 2026 | 356.54 | -4.02% | -4.02% | Third-quarter results confirm guided sequential moderation toward $1.25 billion. Even as high-density UltraFLEXplus shipments remain robust, five percent Treasury yields and restrictive monetary policy force initial multiple contraction from peak levels. |
| Q1 2027 | 345.73 | -3.03% | -6.93% | Fourth-quarter bookings reveal early deceleration as outsourced packaging providers absorb installed tester fleets. Slower order intake prompts institutional profit-taking and multiple compression, partially mitigated by management updating long-term target models. |
| Q2 2027 | 331.14 | -4.22% | -10.86% | Cyclical equipment digestion takes hold across Asian cleanrooms. Sequential revenue softens as customer tool utilization normalizes, triggering downward consensus estimate revisions and driving price-to-earnings ratios toward the mid-thirties. |
| Q3 2027 | 312.37 | -5.67% | -15.91% | Automated test equipment bookings reach an intermediate low as cloud titans review hardware returns. Operating margins experience temporary decremental deleverage, though structural pricing power prevents severe gross margin erosion. |
| Q4 2027 | 305.25 | -2.28% | -17.83% | Order intake stabilizes near trough run-rates as customer test floor utilization rebounds. Fortress balance sheet liquidity, zero net funded debt, and initial CHIPS Act domestic packaging tool deliveries establish a durable pricing floor. |
| Q1 2028 | 294.65 | -3.47% | -20.68% | Early qualification runs for two-nanometer logic architectures and HBM4 memory stacks revive semiconductor test bookings. Teradyne's book-to-bill inflects back toward parity, signaling that the worst of customer capacity absorption has concluded. |
| Q2 2028 | 292.27 | -0.81% | -21.32% | Commercial shipments of specialized PCIe Gen6 and high-power UltraFLEXplus instrumentation gain traction across custom ASIC developers. Sequential revenue turns positive, initiating a steady fundamental recovery from depressed mid-cycle valuations. |
| Q3 2028 | 299.60 | +2.51% | -19.35% | Collaborative robotics orders re-accelerate as factory reshoring and warehouse automation projects commission new workcells. Improving robotics profitability provides valuable revenue diversification, cushioning consolidated margins against remaining semiconductor testing lumpiness. |
| Q4 2028 | 310.33 | +3.58% | -16.46% | Broad-based adoption of multi-die chiplets in AI accelerators mandates longer testing cycles per package. Teradyne captures expanding test cell orders from hyperscalers, driving solid fourth-quarter earnings and prompting share repurchases. |
| Q1 2029 | 322.56 | +3.94% | -13.17% | Early commercial deployment of silicon photonics in optical networking transceivers spurs initial demand for integrated electro-optical test platforms. High-margin instrument sales support gross margins near sixty percent, boosting operating cash generation. |
| Q2 2029 | 331.94 | +2.91% | -10.64% | Volume memory test shipments surge as memory fabricators transition capacity toward next-generation high-bandwidth memory. Operating leverage lifts quarterly net income, prompting institutional capital to rotate back into premier automated test equipment providers. |
| Q3 2029 | 343.86 | +3.59% | -7.43% | Cloud hyperscalers scale secondary custom ASIC programs, utilizing Teradyne test cells for specialized validation. Stable high-margin software licensing fees expand free cash flow conversion, reinforcing balance sheet cash accumulation. |
| Q4 2029 | 356.00 | +3.53% | -4.17% | Solid year-end enterprise capital expenditure commitments sustain high tester utilization rates across merchant and captive foundry lines. Teradyne's annualized revenue run-rate expands, supporting equity price recovery on genuine cash earnings expansion. |
| Q1 2030 | 363.97 | +2.24% | -2.02% | Transition to denser three-dimensional stacked memory and glass substrate architectures increases test vector complexity, driving incremental Magnum platform purchases. Rising average selling prices for advanced instrumentation counteract mature-node volume moderation. |
| Q2 2030 | 375.29 | +3.11% | +1.03% | Universal Robots benefits from the maturation of physical AI vision models, accelerating autonomous cobot penetration across industrial assembly. Consolidated operating leverage delivers steady operating profit growth, sustaining institutional sponsorship. |
| Q3 2030 | 379.98 | +1.25% | +2.29% | Mid-cycle equipment digestion produces routine seasonal revenue plateaus. Disciplined operating expense management preserves operating margins near twenty-eight percent, keeping valuation multiples aligned with broader high-quality capital equipment averages. |
| Q4 2030 | 391.88 | +3.13% | +5.49% | Commercialization of co-packaged optics accelerates across hyperscale datacenters, expanding addressable markets for integrated wafer probing. Teradyne's early instrument lead enables premium pricing and superior incremental operating margins. |
| Q1 2031 | 401.56 | +2.47% | +8.10% | Subsidized packaging fabs across North America and Europe expand production, generating steady automated test equipment installations. Geographic diversification of assembly lines enhances delivery resilience against regional geopolitical friction. |
| Q2 2031 | 411.19 | +2.40% | +10.69% | Autonomous mobile robots achieve widespread penetration across global logistics hubs, accelerating non-semiconductor segment earnings. Robust consolidated operating cash flow supports expanded research into next-generation computing architectures. |
| Q3 2031 | 419.01 | +1.90% | +12.80% | The five-year forecast culminates with Teradyne established as an indispensable compute gatekeeper. Valuation multiples stabilize near twenty-six times normalized earnings, completing the transition from peak cyclicality to durable secular compounding. |
Teradyne occupies an unassailable duopoly in automated test equipment, where the structural migration toward heterogeneous 2.5D/3D chiplets, high-bandwidth memory stacks, and custom cloud ASICs exponentially increases test duration per wafer. However, the equity's current valuation at fifty-one times trailing earnings irrationally capitalizes peak cyclical cleanroom buildouts as permanent annuity cash flows. As outsourced assembly and test providers absorb installed tester fleets and benchmark Treasury yields remain near 5.0%, equipment re-orders will experience a classic cyclical pause. Consequently, healthy underlying through-cycle earnings compounding toward $13 to $14 per share by 2031 will be substantially offset by multiple compression toward twenty-six times earnings.
Key insights
- Tester purchase velocity decouples from chip volume growth as multi-die packaging yield bottlenecks make front-end defect screening economically mandatory.
- Front-loaded customer tool installations inevitably induce multi-quarter absorption pauses, creating acute multiple compression risks despite resilient gross profitability.
- Asset-light outsourced manufacturing provides immense operating leverage during cyclical ramps but generates sharp decremental margin drag during volume digestion phases.
Teradyne makes the specialized testing machines that check advanced artificial intelligence chips and memory stacks for defects before they are assembled into expensive computer servers. While newer and more complex chips require significantly more testing time, the company's stock currently trades at a very high valuation of fifty-one times earnings. Because chip factories recently bought huge fleets of testing equipment all at once, they will soon pause new orders to digest their capacity, meaning future business growth will largely be cancelled out by a cooling stock valuation.
Key insights
- More complex artificial intelligence chips take far longer to test, increasing the long-term need for testing tools.
- Factories recently bought too many machines at once and will soon pause new equipment orders.
- Even though company profits will grow over five years, falling valuation multiples will limit stock returns.
Deep Dive
Prevailing market sentiment views automated test equipment as an unassailable, straight-line beneficiary of the artificial intelligence supercycle, treating recent triple-digit quarterly revenue gains as permanent baseline growth. Sell-side consensus anchors on expanding custom silicon complexity and optimistic price targets above $450, blithely assuming that surging data center investment permanently eliminates historical semiconductor capital goods cyclicality and insulates fifty-times earnings multiples from restrictive monetary policy.